ROCHESTER, Minn. — Findings from a multi-institutional, international study led by researchers from the Mayo Clinic Comprehensive Cancer Center have significantly advanced the understanding of genetic ...
NEW YORK (Reuters) - Quest Diagnostics Inc, the world's largest provider of diagnostic testing services, is working with France's national health agency to build an expanded database for BRCA1 and ...
NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of cancer-focused genetic testing services, announced today the launch of a new line of germline cancer predisposition testing services. The new ...
Zoe Wilson thought she may be at risk. It wasn’t just a vague gut feeling: the risk was demonstrable and clear, running ...
Lifesaving tests for genes that increase risks of breast cancer still aren’t available to Alabama Medicaid recipients, despite a push by advocates who say the agency should offer the screening ...
Medicare Part B covers various genetic tests for diagnosing genetic conditions, identifying cancer risks, and predicting medication responses if a doctor deems them medically necessary. The cost of ...
Phase III Double-Blind Study of Glutamine Versus Placebo for the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy Conclusion: In a clinical setting, we show a high demand ...
Marcy Richardson from Ambry Genetics discusses the importance of a new study that assessed the functional impact of thousands of BRCA2 variants, identifying those that may increase cancer risk. What ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback